long-term follow-up of tafasitamab and lenalidomide in r/r dlbcl
Published 1 year ago • 211 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
1:09
tafasitamab for r/r dlbcl
-
1:17
the latest updates on tafasitamab in dlbcl
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
7:39
líquen plano - doença de pele, como eu curei!
-
21:38
drawing the line: the rationale behind blood tube collection order
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
1:13
long-term follow-up results of the phase i/ii majestec-1 trial
-
1:40
long-term follow-up of the tourmaline-mm1 trial
-
2:23
re-mind2: observational study comparing tafasitamab lenalidomide to available therapies in r/r dlbcl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:09
heart transplantation in attr amyloidosis
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml